SEC Form 4 · accession 0001209191-15-039618
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carol L Brosgart
Director
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1,F2 | $4.25 | May 4, 2015 | A | 4,332 | A | — | Feb 24, 2020 | Common Stock | 4,332 | 4,332 | D |
| Stock Options (right to buy)F1,F2 | $3.14 | May 4, 2015 | A | 4,332 | A | — | Nov 30, 2020 | Common Stock | 4,332 | 8,664 | D |
| Stock Options (right to buy)F1,F3 | $3.51 | May 4, 2015 | A | 4,332 | A | — | Feb 6, 2023 | Common Stock | 4,332 | 12,996 | D |
| Stock Options (right to buy)F1,F4 | $4.81 | May 4, 2015 | A | 18,956 | A | — | Apr 27, 2024 | Common Stock | 18,956 | 31,952 | D |
Explanation of responses
- F1Reporting Person received such stock option in exchange for a stock option to purchase Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Tobira into Issuer (the "Merger"). Pursuant to the terms of the Merger agreement each Tobira stock option assumed will be determined by multiplying the number of options by the exchange ratio of 1.43 and rounding down to the nearest whole number.
- F2The shares are fully vested and exercisable at any time.
- F3These shares shall never vest or become exercisable.
- F46,318 of the shares are vested and exercisable at any time. The remaining 12,638 shares will vest ratably over the next 32 months of continuous service beginning on June 1, 2015, subject to the terms of the Issuer's 2010 Stock Plan.